![]()

| CAS Number | 1202044-20-9 |
| Other Names | MK2866, MK 2866, Ostarine, Enobosarm, Enobosarm-d4 |
| IUPAC Name | (2S)-3-(4-cyano-2,3,5,6-tetradeuteriophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide |
| Molecular Formula | C₁₉H₁₄F₃N₃O₃ |
| Molecular Weight | 389.3 |
| Purity | ≥99% Pure (LC-MS) |
| Storage | Store in cool dry environment, away from direct sunlight. |
| Terms | All products are for laboratory developmental research USE ONLY. Products are not for human consumption. |
Ostarine is an orally-available, non-steroidal SARM that has demonstrated fascinating results in animal, lab studies and trials, and it is currently being explored for a number of different indications. It is being researched for a variety of benefits: increased lean body mass and muscle strength; prevention of muscle loss; prevention of osteoporosis; urinary incontinence due to stress; and treatment of prostate cancer.

CAS: 841205-47-8
Clinical Data
Ostarine has been the subject of two different Phase 2 clinical trials each of which produced positive data regarding its ability to increase strength.




Reviews
There are no reviews yet.